)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Scientific Industries
Scientific Industries (SCND) investor relations material
Scientific Industries Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary31 Mar, 2026
Executive summary
Designs, manufactures, and markets benchtop laboratory equipment and bioprocessing systems, with operations in the US and Germany.
Sold the Genie Division in August 2025, focusing on Torbal® and VIVID® product lines and bioprocessing systems.
Bioprocessing segment remains in start-up phase, requiring ongoing investment and incurring losses.
Financial highlights
Net revenues for 2025 increased 5.4% to $5.05M from $4.80M in 2024, driven by Torbal® sales.
Gross profit margin fell to 25.8% from 41.8% due to inventory write-offs in bioprocessing; adjusted margin would have been 42.6%.
Net loss for 2025 was $1.22M, a significant improvement from $6.45M loss in 2024, aided by a $5.26M gain on the Genie Division sale.
Cash and cash equivalents rose to $955K at year-end 2025 from $588K in 2024.
Accumulated deficit stood at $35.15M as of December 31, 2025.
Outlook and guidance
Management expects continued negative cash flows from operations as bioprocessing investments persist.
Cash from the Genie Division sale and related agreements is expected to fund operations for at least one year.
Future profitability depends on expense reduction, revenue growth, or additional capital.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Scientific Industries
- Net loss narrowed and margins improved, but liquidity and funding remain critical concerns.SCND
Q2 20241 Feb 2026 - Net loss narrowed and sales rose, but liquidity and going concern risks remain.SCNDQ3 202413 Jan 2026
- Annual meeting to vote on director elections, equity plan amendment, and auditor ratification.SCNDProxy Filing29 Dec 2025
- Bioprocessing sales rose 24% in 2024, with cost cuts and a strong pipeline for 2025.SCNDQ4 202425 Dec 2025
- Registering 3.1M shares for resale, company faces losses, liquidity risks, and bioprocessing focus.SCNDRegistration Filing29 Nov 2025
- Bioprocessing-focused growth strategy drives losses; 8M-share resale offering targets capital needs.SCNDRegistration Filing29 Nov 2025
- 3.1M shares registered for resale as company pivots to bioprocessing amid ongoing losses.SCNDRegistration Filing29 Nov 2025
- 3.1M shares registered for resale as company pivots to bioprocessing amid ongoing losses.SCNDRegistration Filing29 Nov 2025
- 3.1M shares registered for resale; company pivots to bioprocessing amid ongoing losses.SCNDRegistration Filing28 Nov 2025
Next Scientific Industries earnings date
Q1 202613 May, 2026
Scientific Industries
Next Scientific Industries earnings date
Q1 202613 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage